Investors expect Medpace Holdings to outperform the market, hence its high P/E ratio. Strong future growth anticipation makes investors pay more for the stock, supporting the share price.
Medpace Holdings' robust conversion of profit to free cash flow is promising. Its underlying earnings potential may even surpass the statutory profit. Its earnings per share have seen a remarkable growth over the past three years.
Medpace Holdings' market sentiment remains steady, mirroring EPS growth. The stock's recent performance shows improvement, with a 90% shareholder return over the last year, surpassing the five-year TSR of 41% per year. The strong share price momentum suggests a closer look at the stock may be worthwhile.
Medpace's high P/E is backed by its forecast growth being higher than the wider market. Investors are quite confident in the company's future earnings and seem willing to pay more for the stock, suggesting a bullish outlook.
Insider selling at current price (US$274) is less worrying, but there were no purchases over the past year to boost confidence. A high level of insider ownership often implies interests of all shareholders are considered, though recent history of share sales triggers some hesitation.
Medpace's market sentiment appears constant over years, mirroring its EPS growth. The company's five-year total shareholder return of 38% per year impresses.
Medpace股票讨论区
新增数据:23Q4,营收快速增长,利润增速有所放缓。
2023年营收增长29.2%,营业利润受毛利率下滑影响增长20.9%,净利润受所得税波动影响增长15.3%。5年净利润平均增速为31%,近3年降到了25%,净资产收益率提高到了60%。
资产负债率从71.4%下降到了66.3%,总资产和净资产都有较大幅度增长。资产端主要是现金的增长,负债端短期借款还清,主要是无息负债有所增长。
现金流经营净额继续大幅高于投资净额,股东盈余很多。
目前市盈率45,估值在合理区间略高位置,由于整体增长趋势和资产负债表都非常优秀,暂时没有调整的必要。
2023Q1营收增长31.2%,营业利润增长34.3%,净利润受所得税波动影响仅增长18.9%。
5年来资产负债率从39%上升到71.4%,应收账款比例和增速都算正常,没有存货。
商誉7亿,是3.47亿净资产的两倍,资产含金量很低。
最近短期借款增长很快,可能是业务增长过快对运营资本需求增大的影响。
股本一直在下降,说明公司回购股票后直接注销,这对每股收益提升很有好处。
5年来现金流经营净额远高于投资净额,股东盈余很多。
目前市盈率33.6,市盈率TTM已经下降到31.2,可以选择(⭐️⭐️)
专栏US Top Gap Ups and Downs on 4/25: SPOT, MEDP, FRC, DB and More
Gap Ups
1. $Medpace(MEDP.US)$ - up 8.3%
2. $哈勃集团(HUBB.US)$ - up 7.3%
3. $诺华制药(NVS.US)$ - up 2.6%
4. $Spotify Technology(SPOT.US)$ - up 1.9%
5. $阿西布朗勃法瑞公司(ABB.US)$ - up 1.8%
6. $康西哥(CNC.US)$ - up 1.5%
7. $金佰利(KMB.US)$ - up 0.9%
8. $野村控股(NMR.US)$ ...
专栏US Top Gap Ups and Downs on 10/25: LOGI, UBS, RBLX, CVS and More
Gap Ups
1. $Medpace(MEDP.US)$ - up 25.01%
2. $罗技(LOGI.US)$ - up 8.07%
3. $瑞银(UBS.US)$ - up 5.36%
4. $SAP SE(SAP.US)$ - up 5.30%
5. $查尔斯河实验室(CRL.US)$ - up 4.30%
6. $艾昆纬(IQV.US)$ - up 3.77%
7. $U-Haul(UHAL.US)$ - up 2.80%
8. $Roblox(RBLX.US)$...
暂无评论